Literature DB >> 3146309

Kufs disease: clinical features and forms.

S F Berkovic1, F Andermann, E Andermann, S Carpenter, L Wolfe.   

Abstract

In patients with an acceptable pathological diagnosis of Kufs disease, two major forms have been identified: Type A presenting as progressive myoclonus epilepsy around the age of 30, and Type B presenting in the same age range with dementia as well as cerebellar and/or extra-pyramidal signs. In adolescence, two subgroups of neuronal ceroid-lipofuscinosis (NCL) emerge. The first group consists of patients resembling either type A or B Kufs disease, but with earlier onset (20% of all cases). These must be distinguished from the second group of rare patients with protracted juvenile NCL presenting with early and prominent visual failure. Although Kufs disease is rare, diagnosis during life should now be possible. The advantages, techniques, and pitfalls of biopsy diagnosis are presented by Carpenter et al. [1988]. We believe that delineation of these two clinical syndromes should aid in the identification of other possible cases of Kufs disease, leading to appropriate pathological examinations to confirm the diagnosis. Knowledge of whether this clinical distinction is biologically meaningful must await the discovery of the more fundamental biochemical defects.

Entities:  

Mesh:

Year:  1988        PMID: 3146309     DOI: 10.1002/ajmg.1320310614

Source DB:  PubMed          Journal:  Am J Med Genet Suppl        ISSN: 1040-3787


  5 in total

Review 1.  Classification and natural history of the neuronal ceroid lipofuscinoses.

Authors:  Jonathan W Mink; Erika F Augustine; Heather R Adams; Frederick J Marshall; Jennifer M Kwon
Journal:  J Child Neurol       Date:  2013-07-09       Impact factor: 1.987

2.  Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease.

Authors:  Chi-Hui Tang; Je-Wook Lee; Michael G Galvez; Liliane Robillard; Sara E Mole; Harold A Chapman
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

3.  Accumulation of the adenosine triphosphate synthase subunit C in the mnd mutant mouse. A model for neuronal ceroid lipofuscinosis.

Authors:  C A Pardo; B A Rabin; D N Palmer; D L Price
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

4.  NCL diseases - clinical perspectives.

Authors:  Angela Schulz; Alfried Kohlschütter; Jonathan Mink; Alessandro Simonati; Ruth Williams
Journal:  Biochim Biophys Acta       Date:  2013-04-17

5.  Localization of juvenile, but not late-infantile, neuronal ceroid lipofuscinosis on chromosome 16.

Authors:  W Yan; R M Boustany; C Konradi; L Ozelius; T Lerner; J A Trofatter; C Julier; X O Breakefield; J F Gusella; J L Haines
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.